The capability of pure and modified boron carbide nanosheet as a nanocarrier for dacarbazine anticancer drug delivery: DFT study
Pramana · 18.03.2024 · 98 (2)
DOI: 10.1007/s12043-023-02701-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pramana, online erschienen am 18.03.2024. Verfasst von Chou-Yi Hsu und 7 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hsu, C., Al-Yasiri, S. A. M., Shather, A. H., Jalil, A., Al-Athari, A. J. H., Mahmoud, Z. H., Hadrawi, S. K., & Kadhim, M. M. (2024). The capability of pure and modified boron carbide nanosheet as a nanocarrier for dacarbazine anticancer drug delivery: DFT study. Pramana, 98(2). https://doi.org/10.1007/s12043-023-02701-2
Vancouver
Hsu C, Al-Yasiri SAM, Shather AH, Jalil A, Al-Athari AJH, Mahmoud ZH, et al. The capability of pure and modified boron carbide nanosheet as a nanocarrier for dacarbazine anticancer drug delivery: DFT study. Pramana. 2024;98(2). doi:10.1007/s12043-023-02701-2
BibTeX
@article{Hsu2024,
author = {Hsu, Chou-Yi and Al-Yasiri, Sarah Alwan Malik and Shather, A H and Jalil, Abdullah and Al-Athari, Ali Jihad Hemid and Mahmoud, Zaid H and Hadrawi, Salema K and Kadhim, Mustafa M},
title = {The capability of pure and modified boron carbide nanosheet as a nanocarrier for dacarbazine anticancer drug delivery: DFT study},
journal = {Pramana},
year = {2024},
volume = {98},
number = {2},
doi = {10.1007/s12043-023-02701-2}
}
EUVIMED